Category Subscribers

Experts In Geneva: Substandard, Falsified Medicines Not About IP

Falsified and substandard medical products continue to be a global concern, and how those products are characterised is important to avoid confusion, particularly with intellectual property rights infringement. A panel convened by Brazil, India and South Africa yesterday at the World Trade Organization looked at the implications of a new definition of such products at the neighbouring World Health Organization.

Broadcasting Treaty Moving At WIPO, Copyright Exceptions For Libraries Not

Positive momentum seems to have been found on a potential global treaty to protect broadcasting organisations as delegates moved towards convergence on some language this week at the World Intellectual Property Organization. Meanwhile, copyright exceptions for actors like libraries and research institutions is meeting the same strong opposition from some, and informal consultations and studies are being set out by the committee chair over the next 18 months, over concerns of delay.

‘Every Great Science Discovery, Invention, Is The Stuff Of Dreams, Not The Stuff Of Reason’: Interview With David Hanson Of Hanson Robotics

Sophia, the well-known human-like robot who acquired citizenship in Saudi Arabia, was at the Artificial Intelligence for Good Global Summit which took place earlier this month in Geneva. Her creator, David Hanson, also CEO and founder of Hanson Robotics, gave an interview to Intellectual Property Watch's Catherine Saez and explained his philosophy about intellectual property, the needed spark of interest in human-like robots, data collection, and innovation.

Hanson is also lead designer and inventor of key technologies including Frubber nanotech, facial expressions and AI software. He is former Walt Disney Imagineering designer, and recipient of numerous awards. A video interview about Sophia is embedded in this text.

IP Rights Through Two Lenses At Next Week’s TRIPS Council: Improving Lives, Competition Law

Next week, the World Trade Organization intellectual property committee is invited to discuss two distinct aspects of intellectual property protection. One group of countries is proposing to explore the value of IP and its role in improving lives in a persistent agenda item on IP and innovation. Another group of countries is pushing for a more recent agenda on IP and the public interest and next week is suggesting to discuss how to use competition laws against the abuse of IP rights.

Controversy Hides Within US Copyright Bill

In a time when partisanship runs wild in the USA and the country’s political parties can’t seem to agree on anything, the Music Modernization Act is exceptional. The MMA passed the House of Representatives on 25 April with unanimous support. And for good reason. Almost all the major stakeholders back this legislation, which will bring some badly needed changes to copyright law’s treatment of music streaming. But wrapped in the MMA is a previously separate bill – the CLASSICS Act – that has been attacked by many copyright law experts, is opposed by many librarians and archivists, and runs counter to policy previously endorsed by the US Copyright Office.

WIPO Copyright Committee Opens With Ideas, Questions On Internet, Terms Of Protection

This week's meeting of the World Intellectual Property Organization copyright committee opened today with what officials perceived as good momentum. Argentina tabled a proposal to help discussions on deferred transmissions in the context of a potential treaty protecting broadcasting organisations, which have been a sticking point in negotiations. Civil society, however, voiced concerns on the provisions of a potential treaty protecting broadcasters against signal piracy, underlining the 50-year envisioned protection and the need to carve out strong limitations and exceptions.

MPP Board Gives Green Light To Expansion, Now Has To Identify Candidates

The Medicines Patent Pool announced this week that its Board agreed on the extension of the MPP mandate to patented medicines on the World Health Organization Essential Medicines List. The decision follows an extensive feasibility study. During a side event held on the margins of the annual World Health Assembly, Patent Pool officials explained the findings of the study, while in the audience, a representative of the pharmaceutical industry suggested a cautious approach.

WHA Agrees On Recommendations To Reinvigorate Plan Of Action To Boost R&D, Access

Ten years after the adoption of a World Health Organization plan of action meant to stimulate innovation for diseases that disproportionately affect developing countries, and with very little to show for it since, delegates at the World Health Assembly this week agreed to a number of recommendations to reinvigorate the effort. How to finance the implementation of those recommendations, however, is unclear.